HIV-1 Reverse Transcriptase drugs for HIV

4 tracked HIV-1 Reverse Transcriptase drugs in the HIV race. The class explanation lives on the HIV-1 Reverse Transcriptase page; the full indication pipeline across every mechanism is on the HIV page.

1 approved / phase 43 Phase 3

Head-to-head evidence: Alimatravir vs Doravirine/islatravir (Idvynso) · Alimatravir vs Islatravir · Alimatravir vs Islatravir/lenacapavir · Doravirine/islatravir (Idvynso) vs Islatravir · Doravirine/islatravir (Idvynso) vs Islatravir/lenacapavir

The roster

← all HIV-1 Reverse Transcriptase drugs